March 9, 2026
As the life sciences industry moves through 2026, hiring activity across the US and UK remains stronger than many expected.
While funding cycles, restructuring, and post-pandemic corrections have made companies more selective, demand for experienced professionals across pharma, biotech, CDMOs, MedTech, and medical supply manufacturing continues to stay high.
The difference in 2026 is not whether companies are hiring — it is where they are hiring, and how difficult it has become to find the right talent.
Across both the United States and the United Kingdom, organisations are focusing recruitment on critical functions tied to regulatory pressure, manufacturing capacity, outsourcing, and complex product development.
After several years of volatility in the life sciences market, hiring has shifted from rapid headcount growth to more precise recruitment.
Companies are still hiring, but they are prioritising specialist experience rather than expanding teams broadly.
Demand remains strong in areas such as:
Recruitment leaders across the UK and US report that the industry is stabilising, but the need for experienced professionals in regulated environments remains high.
At the same time, companies are increasingly looking for candidates who can work across multiple functions, particularly as digital systems, automation, and data-driven processes become more common in R&D and manufacturing.
One of the biggest drivers of recruitment in 2026 is the continued reliance on outsourcing partners.
Pharma and biotech companies are using CDMOs and CMOs more than ever to support:
As more work moves to external partners, CDMOs are expanding technical, quality, and operational teams to keep up with demand.
This shift means hiring pressure is often strongest in organisations supporting production rather than only in sponsor companies.
It also increases demand for candidates with hands-on manufacturing, validation, and regulatory experience.
MedTech and medical device companies in both the US and UK continue to recruit, particularly in areas linked to regulated products, diagnostics, and advanced devices.
Growth in digital health, connected devices, and automated manufacturing is increasing demand for professionals who understand both science and technology.
Roles seeing consistent demand include:
As companies adopt more automated and data-driven systems, candidates with technical and cross-functional skills are becoming harder to find.
Another major factor keeping hiring strong is the increasing complexity of global regulation.
Across the US, UK, and Europe, companies are facing:
As a result, experienced Regulatory, Quality, and Compliance professionals remain among the hardest roles to fill in the life sciences market.
Even in a cautious hiring environment, companies cannot delay recruitment in these areas without risking delays to approvals, launches, or production.
Despite some layoffs in parts of biotech and early-stage companies, the industry is still facing a shortage of experienced professionals.
Recruitment challenges are strongest when companies need people who have:
Hiring leaders are increasingly competing for the same small pool of candidates, especially in the US hubs and major UK life sciences clusters.
This is why hiring remains active even when overall job numbers appear more stable.
For organisations across pharma, biotech, CDMOs, and MedTech, the hiring market in 2026 is defined by precision rather than slowdown.
Companies that can attract and retain experienced talent in quality, regulatory, manufacturing, and technical roles will be better positioned to keep projects moving, maintain compliance, and scale production.
For candidates, this means opportunities still exist — but the strongest demand is for those with specialist experience in regulated, operational, or technical environments.
And for employers, the challenge remains the same:
The roles are open.
The projects are active.
But finding the right people is harder than ever.
© All rights reserved